Resume

• 2001

  Joseph

  Agyin

  University of Texas Health Science Center at San Antonio

  South Texas Technology Management

  Responsible for all initiatives of a chemical synthesis and drug development research laboratory; design and synthesize novel anticancer compounds for preclinical studies; seventeen years of experience in multi-step organic synthesis; write research grants that are funded by the National Institutes of Health/National Cancer Institute (NIH/NCI) (R21 and KO1 grants)

  the Helen Freeborn Kerr Foundation (Bank of America) and San Antonio Area Foundation. Publish original research findings in reputed international scientific journals

  and inventor on several issued U.S. patents; present research findings at international conferences; train postdoctoral Research Fellows and undergraduate students. Peer-review manuscripts for national and international scientific journals such as the European Journal of Medicinal Chemistry

  Nanomaterials and Nanotechnology Journal (NMNT)

  Complementary and Alternative Medicine (CAM)

  and Cell Biology and Toxicology (CBT). Served as Chair of the Chemical Safety Committee and a member of the International Relations Committee. Strong expertise in analytical chemistry techniques such as NMR

  HPLC

  GC

  TLC

  Mass spectrometry

  and column chromatography. Experience in cancer research

  construction and application of preclinical models and therapeutic efficacy assessment strategies. Strong expertise in project management. Write job descriptions

  recruits

  trains

  evaluates and rewards lab personnel; monitors

  evaluates and initiates quality control

  assurance and improvement activities for lab processes. Ensures that lab’s operating procedures and policies are in alignment with institutional

  state and federal policies and standards. Responsible for the formulation

  implementation

  execution and monitoring of benchmarks

  procedures and practices utilizing resources such as personnel

  budgets

  supplies and equipment to yield consistent quality results.

  University of Texas Health Science Center at San Antonio

  UTHSCSA

  Licensing Associate

  Managed University intellectual property portfolio

  including inventions in the areas of life

  physical

  and materials sciences

  nanotechnology

  pharmaceuticals

  imaging

  tissue engineering

  genomics and proteomics. Evaluated invention disclosures submitted by faculty members to determine patentability; performed due diligence on license agreements. Directed patent prosecution of University IP in collaboration with outside legal counsel. Executed technology transfer of University inventions

  i.e.

  evaluated inventions

  performed prior art searches

  formulated a licensing strategy

  identified and marketed to appropriate firms. Drafted and negotiated legal contracts

  i.e.

  cda

  mta

  option

  sponsored research

  and license agreements

  in order to implement commercialization strategy. Determined commercial value/market potential of inventions. Prepared marketing fliers on new technologies.

  South Texas Technology Management

• 1991

  PhD

  Organic Chemistry

  American Chemical Society

• 1988

  MS

  Organic Chemistry

• 121

  Jim Quada

  Benzimidazole derivatives and salts and prodrugs thereof are disclosed

  together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.

  + Add another inventor

  James Camden

• Cancer

  Analytical Chemistry

  Organic Chemistry

  Technology Transfer

  Commercialization

  Genomics

  Organic Synthesis

  HPLC

  Drug Development

  Clinical Research

  Pharmaceutical Industry

  Clinical Development

  Protein Chemistry

  Science

  Intellectual Property

  Cell Biology

  Biotechnology

  NMR

  Patents

  Lifesciences

  Agyin